[Federal Register Volume 63, Number 131 (Thursday, July 9, 1998)]
[Notices]
[Pages 37139-37140]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-18222]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on April 1, 1998, Research
Biochemicals, Inc., which has changed its name to Sigma-Aldrich
Research Biochemicals, Inc., One Three Strathmore Road, Attn: Richard
A. Milius PhD, Natick, Massachusetts 01760, made application by renewal
to the Drug Enforcement Administration (DEA) for registration as a bulk
manufacturer of the basic classes of controlled substances listed
below.
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)........................... I
Methcathinone (1237)....................... I
4-Bromo-2,5-dimethoxyamphetamine (7391).... I
4-Bromo-2,5-dimethoxyphenethylamine (7392). I
2,5-Dimethoxyamphetamine (7396)............ I
3,4-Methylenedioxyamphetamine (7400)....... I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine I
(7404).
3,4-Methylenedioxymethamphetamine (7405)... I
1-[1-(2-Thienyl)cyclohexyl]piperidine I
(7470).
Heroin (9200).............................. I
Methamphetamine (1105)..................... II
Phencyclidine (7471)....................... II
Benzoylecgonine (9180)..................... II
------------------------------------------------------------------------
[[Page 37140]]
The firm plans to import small quantities of the listed controlled
substance to manufacture laboratory reference standards and
neurochemicals.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substances may file comments or objections
to the issuance of the proposed registration.
Any such comments or objections may be addressed, in quintuplicate,
to the Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration, United States Department of Justice,
Washington, D.C. 20537, Attention: DEA Federal Register Representative
(CCR), and must be filed no later than September 8, 1998.
Dated: June 30, 1998.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 98-18222 Filed 7-8-98; 8:45 am]
BILLING CODE 4410-09-M
